Chemotherapy for non‐Hodgkin lymphoma in the hemodialysis patient: A comprehensive review
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Science"
DOI: 10.1111/cas.14933
Abstract: Chemotherapy for non‐Hodgkin lymphoma (NHL) in the hemodialysis (HD) patient is a challenging situation. Because many drugs are predominantly eliminated by the kidneys, chemotherapy in the HD patient requires special considerations concerning dose adjustments to… read more here.
Keywords: chemotherapy; hodgkin lymphoma; hemodialysis patient; chemotherapy non ... See more keywords
Impact of adjuvant chemotherapy in non-metastatic node positive bronchial neuroendocrine tumors (BNET).
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.8533
Abstract: 8533Background: BNET are a rare and frequently indolent group of neoplasms. Lobectomy is frequently done for patients with non-metastatic disease, and the role of adjuvant chemotherapy for patients... read more here.
Keywords: adjuvant chemotherapy; chemotherapy non; impact adjuvant; metastatic node ... See more keywords
Patient Perspectives and Side-Effects Experience on Chemotherapy of Non-Small Cell Lung Cancer: A Qualitative Study
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Management and Research"
DOI: 10.2147/cmar.s396751
Abstract: Purpose This study aimed to explore patients’ experiences of palliative chemotherapy for non-small cell lung cancer (NSCLC), how patients adapt to their new and challenging life after chemotherapy, their beliefs, and their quality of life.… read more here.
Keywords: experience; side effects; chemotherapy non; chemotherapy ... See more keywords